PRTA Jan 2025 22.500 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

6.80

0.00

(0.00%)

As of 01:29PM EDT. Market open.

Loading interactive chart...

Business Wire
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
Simply Wall St.
News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
Celebrations may be in order for Prothena Corporation plc ( NASDAQ:PRTA ) shareholders, with the analysts delivering a...
Simply Wall St.
Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results
The analysts might have been a bit too bullish on Prothena Corporation plc ( NASDAQ:PRTA ), given that the company fell...